ArticleScientific reports2025
Prevalence and associated factors of overweight and obesity among people living with HIV on antiretroviral therapy in a national hospital in Benin.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16A.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overweight and obesity are major global public health concerns, and they are increasingly recognized as side effects of long-term antiretroviral therapy (ART) in people living with HIV (PLHIV). As ART improves life expectancy, weight gain and associated comorbidities have emerged as new challenges in HIV care. This study aimed to determine the prevalence and associated factors with overweight and obesity among people living with HIV(PLHIV) on antiretroviral therapy (ART) in Benin's National Teaching Hospital. A prospective cross-sectional study was conducted over a three-month period, from December 17, 2023, to February 10, 2024. Data were collected through structured interviews and medical record reviews. Statistical analyses included descriptive statistics, univariable, and multivariable logistic regression to assess associations between overweight/obesity and demographic, clinical, and lifestyle factors. The prevalence of overweight and obesity in the study population was 49.4%, with a significantly higher prevalence in females (36.8%) than males (12.6%). Multivariable analysis identified female sex (aOR: 2.4; 95% CI: 1.5-4.1; p < 0.001) and hypertension (aOR: 2.5; 95% CI: 1.6-4.1; p < 0.001) as strong independent predictors of overweight and obesity. Conversely, a high viral load (> 1000 copies/ml) was inversely associated with excess weight (aOR: 0.4; 95% CI: 0.2-0.9; p = 0.050). In summary, nearly half of PLHIV on ART were overweight or obese. Female sex and hypertension increased the risk, while high viral load was linked to lower weight. These findings underline the need for integrated care approaches that address weight management in HIV treatment programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.